Item 8.01 Other Events.

On November 17, 2020, Akers Biosciences, Inc. (the "Company") closed a previously announced private placement of 9,765,933 shares of its common stock and warrants to purchase 9,765,933 shares of its common stock resulting in aggregate gross proceeds to the Company of approximately $18.1 million (the "Private Placement"). In connection with the Private Placement and pursuant to a previously reported engagement letter entered into by and among the Company and Katalyst Securities LLC (the "Placement Agent"), the Company also issued the Placement Agent a warrant to purchase up to 390,368 shares of the Company's common stock at an exercise price of $1.85 (the "Placement Agent Warrant"). The Placement Agent Warrant will be exercisable at any time and from time to time, in whole or in part, following the date of issuance and for a term of five and a half years.

A form of the Placement Agent Warrant is attached hereto as Exhibit 4.1 and is incorporated herein by reference. The description of the Placement Agent Warrant herein does not purport to be complete and is qualified in its entirety by reference to Exhibit 4.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit Number               Description
4.1                Form of Placement Agent Warrant

© Edgar Online, source Glimpses